Literature DB >> 10218351

[Rational hemostatic screening].

N Maurin1.   

Abstract

BACKGROUND: In order to exclude hemorrhagic diathesis, e.g. before diagnostic measures carrying the risk of bleeding or in preoperative situations, a graded screening is advisable. PROCEDURE: During the first stage, besides the anamnesis, clinical examination and classification of relevant concomitant diseases (e.g. liver cirrhosis or renal insufficiency), basic laboratory examinations such as prothrombin time, activated partial thromboplastin time (aPTT) and platelet count must be carried out. Should all these measures produce no noteworthy results, no further examinations are necessary. However, in the case of test results within normal limits accompanied by an unsatisfactory anamnesis and/or conspicuous clinical findings, the second stage should include examination of bleeding time according to Mielke to exclude a relevant platelet dysfunction. Should this be inconspicuous a third stage should follow in which successive implementation is made of fibrinogen according to Clauss, the Rumpel-Leede test (to exclude heightened capillary fragility), factor XIII and alpha 2-antiplasmin. The methodical snares of the parameters mentioned will be explained in full.

Entities:  

Mesh:

Year:  1999        PMID: 10218351     DOI: 10.1007/BF03044847

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  24 in total

1.  Salicylates and bleeding: the aspirin tolerance test.

Authors:  A J Quick
Journal:  Am J Med Sci       Date:  1966-09       Impact factor: 2.378

2.  The standardized normal Ivy bleeding time and its prolongation by aspirin.

Authors:  C H Mielke; M M Kaneshiro; I A Maher; J M Weiner; S I Rapaport
Journal:  Blood       Date:  1969-08       Impact factor: 22.113

3.  WHO Expert Committee on Biological Standardization. Thirty-third report.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1983

4.  Preoperative hemostatic evaluation: which tests, if any?

Authors:  S I Rapaport
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

5.  Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations.

Authors:  S R Babson; A L Babson
Journal:  Am J Clin Pathol       Date:  1978-09       Impact factor: 2.493

6.  Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.

Authors:  E C Williams
Journal:  Arch Intern Med       Date:  1989-08

7.  The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders.

Authors:  M J Stuart; M L Miller; F R Davey; J A Wolk
Journal:  Br J Haematol       Date:  1979-12       Impact factor: 6.998

8.  Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA.

Authors:  M J Mant; J C Doery; J Gauldie; H Sims
Journal:  Scand J Haematol       Date:  1975-10

9.  [Pseudothrombocytopenia--an error in the determination of thrombocyte count].

Authors:  B Rosenkranz; H Wisser; J C Bode
Journal:  Dtsch Med Wochenschr       Date:  1985-03-29       Impact factor: 0.628

10.  The bleeding time as a preoperative screening test.

Authors:  A Barber; D Green; T Galluzzo; C H Ts'ao
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

View more
  1 in total

Review 1.  [Significance of platelet function tests].

Authors:  Z Wolf; H Mani; E Lindhoff-Last
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.